Skip to main content
Caplight Logo









OstomyCure AS

OstomyCure AS

Private
OsloHealthcare & Life Scienceshttps://ostomysecure.com/

Last Round

Early Funding

Jul 1, 2026

Total Funding Raised

$5.68M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

OstomyCure AS is a medical technology company that develops and markets the TIES® System, a titanium implant solution designed to replace conventional ileostomy bags for patients with stomas.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Keywords

medical implantostomystoma bag alternativecolostomyTranscutaneous Implant Evacuation SystemTIESsurgical devicestoma caregastroenterologymedical deviceostomy suppliestitanium implantclinical trial

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OstomyCure AS Comparables

Compare OstomyCure AS with similar companies based on industry and business-model similarity.

OstomyCure AS comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
OriVa
82%
Implantica AG
79%
Ampa Medical
79%

OstomyCure AS Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingJul 1, 2026
GrantFeb 20, 2019
GrantJan 1, 2019

Key People

Founding team and executive leadership

Graeme L. Smith

Chief Executive Officer, Executive Chair

Executive Team

OstomyCure AS Investors

Notable investors and investment history

OstomyCure AS investors
InvestorRounds
European CommissionGrant
KistefosEarly Funding, Private Equity
Inven2Private Equity, Early Funding
CanicaPrivate Equity, Early Funding
Innovasjon NorgeGrant, Private Equity
The Research Council of NorwayGrant, Private Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 1, 2026

    $14.3M raised from Canica, Kistefos, and Inven2.

  • Mar 1, 2026

    Grew 44% QoQ from 9 to 13 employees.

OstomyCure AS Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

OstomyCure AS Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about OstomyCure AS's valuation, stock price, and market status.

Firmographic Details

HeadquartersOslo
Employee Range13
Year Founded2004
Last FundingJul 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?